Trogarzo
Payments companies reported to CMS as associated with Trogarzo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trogarzo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trogarzo
These are the largest totals companies reported as associated with Trogarzo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jihad Slim | Newark, NJ | Infectious Disease | $38,089.49 |
| Stephen Weinroth | Fairfax, VA | Infectious Disease | $12,261.55 |
| Brinda Emu | New Haven, CT | Infectious Disease | $10,123.92 |
| Edward Braun | St Petersburg, FL | Family Medicine | $9,020.53 |
| Harish Moorjani | Briarcliff Manor, NY | Infectious Disease | $8,245.57 |
| Charles Flexner | Baltimore, MD | Internal Medicine | $7,899.17 |
| Gary Sinclair | Dallas, TX | Internal Medicine | $6,993.74 |
| Michelle Collins-Ogle | Bronx, NY | Adolescent Medicine (Pediatrics) | $4,642.43 |
| Claudia Martorell | Springfield, MA | Infectious Disease | $3,936.66 |
| Robin Beach | Houston, TX | Family | $3,665.08 |
Prescribed Trogarzo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.